In a first-in-human study, intranasal transplantation of mesenchymal stromal cells was safe and well-tolerated in newborns who had suffered a stroke — laying the foundation for large-scale clinical trials.

中文翻译：

---

新生儿缺血性卒中细胞治疗的第一步

在一项首次人体研究中，间充质基质细胞的鼻内移植在患有中风的新生儿中是安全且耐受性良好的——为大规模临床试验奠定了基础。